Company: ABBV
Filing Date: 2025-03-10
Form Type: PRE 14A
Source: 0001558370-25-002603
Chunk: 6

Company: AbbVie Inc.
Filing Date: 2025-03-10
Form: PRE 14A
Chunk 6
---
 complex health challenges and create remarkable impacts on people’s lives.​Business EthicsWe act with integrity in everything we do. | Patient Health and EngagementWe continuously strive to improve health outcomes for patients around the world. ​Product Quality and SafetyWe are committed to delivering safe and effective, quality products and medicines through robust quality systems. |

We also prioritize Environmental Sustainability within and beyond AbbVie to support our patients, people, and planet. Our environmental sustainability strategy is focused on reducing our environmental footprint, growing sustainably by inspiring innovation, and engaging our workforce to steward sustainability.

2025 Proxy Statement |7

#### ​​PROXY SUMMARY​​

#### Our ESG Governance​AbbVie’s full Board of Directors, Board committees, and executive leadership team regularly review, and advise on, ESG topics to advance AbbVie’s business sustainability and impact on society. To further strategic and enterprise-aligned delivery on AbbVie’s ESG Framework, we maintain an ESG Council, chaired by our Senior Vice President, Corporate Affairs, and composed of senior-level leaders from across the company. The ESG Council’s purpose is to champion business sustainability and mitigate business risks by monitoring, reviewing, and recommending actions to the ESG Council Chair, members of the executive leadership team, and AbbVie’s CEO. The ESG Council Chair may also present certain recommendations of the ESG Council from time to time to the Board of Directors as appropriate.​The ESG Council meets regularly and maintains sub-committees that are aligned to AbbVie’s material drivers. With this governance in place, AbbVie is well-positioned to recognize ESG opportunities and advance its ESG objectives.​​ESG Action Report​In 2024, we further strengthened our ESG Action Report by enhancing transparency of our ESG strategies and efforts. Published in May 2024, the 2023 ESG Action Report includes detailed commentary about our approach, actions, and commitments across material drivers; over 100 KPIs showing our progress; and ESG-related recognitions of our efforts. The ESG Action Report also outlines our alignment with United Nations Sustainable Development Goals (SDGs) and the Sustainability Accounting Standards Board (SASB) Index. The full 2023 ESG Action Report can be found at https://www.abbvie.com/content/dam/abbvie-com2/pdfs/abbvie-esg-action-report.pdf​​​Double Materiality Assessment​In 2024, AbbVie conducted a double materiality assessment to inform our ESG